Miami, FL, Dec. 31, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced plans to launch a shareholder rewards program delivering a tangible, real-world benefit through its EzFill platform. Once launched, shareholders will receive a digital fuel-discount coupon token deposited directly into their EzFill mobile app accounts. Upon receipt, the token may be redeemed for one fueling event at a ...

ST. PETERSBURG, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or “Company”), parent company of BayFirst National Bank (“Bank”) today announced that it will report its fourth quarter results after the market close on Thursday, January 29, 2026. Management will host a conference call on Friday, January 30, 2026, at 9:00 a.m. ET to discuss the results. The call will also be broadcast live via the internet. Interested investors may listen to the call live under the ...

Core Insights - Intelligent Bio Solutions Inc. (INBS) has formed a strategic manufacturing partnership with Syrma Johari MedTech to enhance its production capabilities and support its entry into the U.S. market in 2026 [1][3]. Group 1: Partnership Benefits - The partnership is expected to yield annual production cost savings exceeding 40%, leading to an anticipated improvement of approximately 20 percentage points in gross margin compared to previous manufacturing arrangements [2]. - Syrma Johari's manufacturing capacity is about four times that of INBS, enabling the company to efficiently meet anticipated demand as it scales its commercial operations [2]. Group 2: Supply Chain Resilience - This collaboration strengthens INBS' global manufacturing strategy by reducing reliance on a single supplier and enhancing supply chain resilience [3]. - The partnership broadens manufacturing capacity, ensures continuity, and creates flexibility in preparation for future demand across multiple regions [3]. Group 3: Syrma Johari's Capabilities - Syrma Johari has over 45 years of experience in medical device engineering and manufacturing, operating 14 manufacturing locations and four design and innovation centers globally [4]. - The company is certified to ISO 13485, MDSAP, FDA, TUV SUD, and GMP standards, ensuring high compliance and quality in medical device manufacturing [4]. Group 4: Production Efficiency - Syrma Johari's vertical integration and export-oriented model facilitate high-quality production while optimizing sourcing, tooling, testing, and logistics [5]. - The company is set to open a new medical-grade plastics manufacturing facility in India in January 2026, further enhancing its capabilities to meet global demand [5]. Group 5: Regulatory Support - Syrma Johari's extensive regulatory and quality-assurance capabilities align with INBS' global expansion plans, providing end-to-end quality systems and regulatory documentation support [6]. - This expertise will assist INBS in advancing its regulatory pathways and preparing for increased commercial activity worldwide [6]. Group 6: Strategic Importance - The partnership is viewed as a significant milestone for INBS, enhancing its supply chain and supporting future growth [7]. - Both companies express a strong alignment in innovation, quality, and long-term vision, indicating a commitment to scaling disruptive drug-screening technology [7][8].

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the filing of a Phase 1/2 Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) seeking regulatory clearance to initiate clinical trials of CY ...

SARASOTA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, today announced plans to distribute a new digital token to its shareholders in partnership with Crypto.com. The distribution is expected to leverage Crypto.com’s cutting-edge technology, including the high performance, interoperable Cronos blockchain designed for s ...

SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on We ...

JIAXING, China, Dec. 31, 2025 (GLOBE NEWSWIRE) -- On December 10, 2025, at a high-level symposium on high-standard opening-up and high-quality development held in Jiaxing, China, a foreign entrepreneur drew wide attention by sharing his “Jiaxing story” in fluent Chinese.He was Simon Lichtenberg, a Danish entrepreneur, an Honorary Citizen of Shanghai, and a recommender of the China International Import Expo (CIIE) for the eighth time.The symposium served not only as a platform to review and look ahead to Jia ...

Bagsværd, Denmark, 31 December 2025 – Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to the semaglutide compound patent. Novo Nordisk is pleased that the Court has upheld the Beijing IP Court ruling recognising the validity of the semaglutide compound patent. “This outcome is very positive for semaglutide and demonstrates firm government support for protecting medical innovation,” said Mike Doustdar, president and CEO of Novo Nordisk. ...

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCID: HYOR), a clean-energy technology company, today announced the successful completion of the Factory Acceptance Test (FAT) for its 500kW Organic Rankine Cycle (ORC) turbine, which is now being prepared for shipment to Camsan Ordu, a customer project in Turkey. The FAT was witnessed and independently inspected by Bureau Veritas, a global testing, inspection, and certification group. The inspection was carried out on 30 December 2025 at the Hy ...

Core Viewpoint - Reeflex Solutions Inc. has received a management cease trade order (MCTO) from the Alberta Securities Commission due to the inability to file its audited annual financial statements by the required deadline [1][2]. Group 1: Management Cease Trade Order (MCTO) - The MCTO restricts the Company's CEO and CFO from trading in the Company's securities until the Annual Filings are completed, but it does not affect the general investing public's ability to trade [2]. - The Company applied for the MCTO because it could not file its audited annual financial statements, management's discussion and analysis, and related CEO and CFO certifications for the financial year ended August 31, 2025, by the deadline of December 29, 2025 [2]. Group 2: Transition and Audit Challenges - The Company transitioned from a private, family-owned business to a public company through a reverse takeover transaction on May 16, 2025, and acquired Coil Solutions Inc. on May 15, 2025 [3]. - The year-end was changed from December 31, 2025, to August 31, 2025, to align with its operating subsidiary, CSI [3]. - The new auditor, MNP LLP, indicated that the interim financial statements for the quarter ended May 31, 2025, need to be restated to reflect CSI's results from the acquisition date, which has delayed the audit of the year-end results and the preparation of the Annual Filings [3]. Group 3: Filing Expectations and Compliance - The Company is working diligently to complete the Annual Filings and the restatement of its Q3 Filings, expecting to finalize these by approximately January 29, 2025 [4]. - The Company will issue bi-weekly status reports as required under NP 12-203 until the Annual Filings are completed [4]. - As of the announcement date, the Company confirms no material changes regarding the default, no failures in fulfilling stated intentions, and no other specified defaults under NP 12-203 [5]. Group 4: Company Overview - Reeflex Solutions Inc. provides advanced engineering and manufacturing solutions across various sectors, including coiled tubing injectors and downhole tools for the oil and gas industry through its subsidiary, Coil Solutions Inc. [6].